AstraZeneca shares plunge as Wainua fails late-stage heart disease trial
AstraZeneca shares slumped nearly 10% on Thursday after the drugmaker said its nerve disease treatment Wainua failed to achieve the…
AstraZeneca shares slumped nearly 10% on Thursday after the drugmaker said its nerve disease treatment Wainua failed to achieve the…
Key Points Axsome Therapeutics (NASDAQ: AXSM) and Revolution Medicines (NASDAQ: RVMD) have offered investors significant growth so far this year.…
Key Points Stocks have roared higher in recent years, and even after headwinds in the first quarter, the market continued…
UK housebuilders are under intense pressure this year. Barratt Redrow shares have dropped by 27%, while Taylor Wimpey, Barratt Redrow,…
Microsoft’s warning that the quantum-security clock is moving faster has put a beaten-down quantum stock back on Wall Street’s radar.…
Key Points Data reveals that most middle-aged to older Americans would be well-served claiming Social Security at 70. Only roughly…
The latest episodes, articles, and market insights, delivered to your inbox. No noise, just signal.
Join 25,000+ readers. No spam, ever.
Eagle One Intelligence
Macro shifts, market structure, and the ideas worth tracking — straight to your inbox before the crowd figures it out.